Life on the inside: Probing Mycobacterium tuberculosis gene expression during infection

Immunology and Cell Biology

Volumn 78, Issue 4, 2000, Pages 311-317

  Triccas, James A ^a   Gicquel, Brigitte ^b  

^a CENTENARY INSTITUTE   (Australia)

^b INSTITUT PASTEUR   (France)

Author keywords

Gene; In vivo expression; Infection; Tuberculosis; Vaccine; Virulence

Indexed keywords

BCG VACCINE; COMPLEMENTARY DNA; DNA VACCINE; RIBOSOME DNA;

ADAPTATION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BCG VACCINATION; GENE EXPRESSION; GENE MUTATION; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; TUBERCULOSIS; VACCINATION;

ANIMALS; BCG VACCINE; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENETIC TECHNIQUES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; PROKARYOTA;

EID: 0033846598     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2000.00934.x     Document Type: Review

References (60)

1. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic
2. Drug-resistant and multidrug-resistant tubercle bacilli
3. Mycobacterial infections in clinical immunology
4. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis
5. Prospects for new interventions in the treatment and prevention of mycobacterial disease
6. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
7. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis
8. Characterization of the Mycobacterium tuberculosis phagosome
9. A coat protein on phagosomes involved in the intracellular survival of mycobacteria
10. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase
11. Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes
12. Dissecting the biology of a pathogen during infection
13. Fluorescence-based isolation of bacterial genes expressed within host cells
14. Strategies for isolation of in vivo expressed genes from bacteria
15. Understanding, improving and using green fluorescent proteins
16. Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages
17. Green fluorescent protein as a new expression marker in mycobacteria
18. The identification of Mycobacterium marinum genes differentially expressed in macrophage phagosomes using promoter fusions to green fluorescent protein
19. Use of fluorescence induction and sucrose counterselection to identify Mycobacterium tuberculosis genes expressed within host cells
20. Expression of the Bacillus subtilis sacB gene confers sucrose sensitivity on mycobacteria
21. Generation of unmarked directed mutations in mycobacteria, using sucrose counter-selectable suicide vectors
22. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis human macrophages by selective capture of transcribed by sequences (SCOTS)
23. Simultaneous identification of bacterial virulence genes by negative selection
24. Identification of aureus Staphylococcus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis
25. Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization
26. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments
27. Large-scale identification of virulence genes from Streptococcus pneumoniae
28. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis
29. Selection of bacterial virulence genes that are specifically induced in host tissues
30. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization
31. Comparative genomics of BCG vaccines by whole-genome DNA microarray
32. Role of oxidants in microbial pathophysiology
33. Identification of novel chromosomal loci affecting Yersinia enterocolitica pathogenesis
34. Bacterial infection as assessed by in vivo gene expression
35. Analysis of the Streptomyces coelicolor sigE gene reveals the existence of a subfamily of eubacterial RNA polymerase sigma factors involved in the regulation of extracytoplasmic functions
36. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: Environmental stress and regulation of bacterial virulence by alternative sigma factors
37. The rpoE gene of Escherichia coli, which encodes sigma E, is essential for bacterial growth at high temperature
38. A mycobacterial extra-cytoplasmic function sigma factor involved in survival following stress
39. A mycobacterial extracytoplasmic sigma factor involved in survival following heat shock and oxidative stress
40. Conditional sigma factor expression, using the inducible acetamidase promoter, reveals that the Mycobacterium tuberculosis sigF gene modulates expression of the 16-kilodalton alpha-crystallin homologue
41. The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages
42. Elements of signal transduction in Mycobacterium tuberculosis: In vitro phosphorylation and in vivo expression of the response regulator MtrA
43. Mg2+ as an extra-cellular signal: Environmental regulation of Salmonella virulence
44. Identification of novel staphylococcal virulence genes by in vivo expression technology
45. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
46. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria
47. The envelope of mycobacteria
48. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: Effect on growth in culture and in macrophages
49. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: Extracellular proteins as potential novel drug targets
50. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene
51. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine
52. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
53. Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties
54. Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex
55. Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor
56. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages
57. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analyses of the published literature
58. New vaccines against tuberculosis. The status of current research
59. Does the efficacy of BCG decline with time since vaccination?
60. Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells